cyclosporine has been researched along with Hemophilia B in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cross, DC; Van Der Berg, HM | 1 |
Bellinger, DA; Cross, RE; Eisensmith, RC; Fang, B; Gordon, G; Hu, PC; Kay, MA; Landen, CN; Read, MS; Wang, H | 1 |
2 other study(ies) available for cyclosporine and Hemophilia B
Article | Year |
---|---|
Cyclosporin A can achieve immune tolerance in a patient with severe haemophilia B and refractory inhibitors.
Topics: Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Factor IX; Hemophilia B; Humans; Immune Tolerance; Immunosuppressive Agents; Isoantibodies; Male; Nephrotic Syndrome; Recurrence | 2007 |
Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression.
Topics: Adenoviridae; Animals; Antibodies, Viral; Blood Coagulation; Cyclosporine; Dogs; Factor IX; Genetic Therapy; Genetic Vectors; Hemophilia B; Immunosuppression Therapy; Immunosuppressive Agents; Neutralization Tests | 1995 |